Abstract
Background: Defective branched-chain amino acid (BCAA) catabolism is central to the pathogenesis of obesity, insulin resistance (IR) and heart disease. Branched-chain α-keto acids (BCKAs), a catabolic product of BCAAs, is oxidized in the mitochondria by branched-chain ketoacid dehydrogenase (BCKDH), an enzyme sensitive to inhibitory phosphorylation by BCKD kinase (BCKDK). BCAAs activate mTORC1, which causes IR by inhibiting insulin signalling. However, the effect of BCKA on muscle insulin signalling is unexplored.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
